Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$3.11M
10 trades · 3 insiders
Net · 90d
$-3.11M
Insiders on file
24
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Cohlhepp Ryan | President, COO & Interim CEO, Director | 65 | $0 | $5.52M | 2026-09-08 |
| Larson Jennifer | Chief Financial Officer | 2 | $0 | $0 | 2026-08-12 |
| Mazumdar Claire | Chief Executive Officer, Director | 59 | $0 | $4.34M | 2026-08-10 |
| Hyep Ivan | Chief Financial Officer | 54 | $0 | $3.59M | 2026-08-10 |
| Bender Jeremy | Director | 2 | $0 | $0 | 2026-07-28 |
| Oliger Christy J. | Director | 2 | $0 | $0 | 2026-07-28 |
| Mazumdar-Shaw Kiran | Director, 10% Owner | 11 | $0 | $0 | 2026-06-09 |
| Robertson Scott M. | Director | 3 | $0 | $0 | 2026-06-09 |
| Simson Jake | Director | 3 | $0 | $0 | 2026-06-09 |
| Haviland Kate | Director | 3 | $0 | $0 | 2026-06-09 |
| Shah Rajeev M. | Director, 10% Owner | 1 | $0 | $0 | 2026-06-09 |
| Bowden Christopher | Director | 2 | $0 | $0 | 2026-06-09 |
| POWELL MICHAEL | Director | 2 | $0 | $0 | 2026-06-09 |
| Schelman William | Chief Medical Officer | 1 | $0 | $0 | 2026-05-08 |
| Raben David | Chief Medical Officer | 27 | $0 | $1.15M | 2026-04-27 |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | 3 | $40.00M | $0 | 2026-02-26 |
| Meisner Lara | Chief Legal Officer | 17 | $0 | $1.87M | 2026-02-02 |
| RA Capital Nexus Fund III, L.P. | Director | 9 | $32.99M | $0 | 2025-06-09 |
| LONBERG NILS | Director | 2 | $0 | $0 | 2025-06-09 |
| Deerfield Private Design Fund V, L.P. | 10% Owner | 6 | $1.26M | $0 | 2024-09-17 |
| BONDERMAN DAVID | Other | 2 | $0 | $0 | 2024-09-16 |
| FIL Ltd | Other | 6 | $0 | $0 | 2024-09-16 |
| FMR LLC | Other | 6 | $0 | $0 | 2024-09-16 |
| Biocon Ltd | 10% Owner | 4 | $0 | $0 | 2024-09-16 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan | President, COO & Interim CEO | M Exercise deriv | 2026-09-08 | 2026-09-10 | 17,500 | — | $0 | 34,252 | SEC↗ |
| Cohlhepp Ryan | President, COO & Interim CEO | M Exercise | 2026-09-08 | 2026-09-10 | 17,500 | $3.79 | $66.3K | 199,141 | SEC↗ |
| Cohlhepp Ryan | President, COO & Interim CEO | S Sale | 2026-09-08 | 2026-09-10 | 14,058 | $22.77 | $320.1K | 185,083 | SEC↗ |
| Cohlhepp Ryan | President, COO & Interim CEO | S Sale | 2026-09-08 | 2026-09-10 | 3,442 | $23.43 | $80.6K | 181,641 | SEC↗ |
| Cohlhepp Ryan | President, COO & Interim CEO | M Exercise deriv | 2026-09-08 | 2026-09-10 | 17,500 | — | $0 | 34,252 | SEC↗ |
| Cohlhepp Ryan | President, COO & Interim CEO | S Sale | 2026-09-08 | 2026-09-10 | 3,442 | $23.43 | $80.7K | 181,641 | SEC↗ |
| Cohlhepp Ryan | President, COO & Interim CEO | S Sale | 2026-09-08 | 2026-09-10 | 14,058 | $22.77 | $320.1K | 185,083 | SEC↗ |
| Cohlhepp Ryan | President, COO & Interim CEO | M Exercise | 2026-09-08 | 2026-09-10 | 17,500 | $3.79 | $66.3K | 199,141 | SEC↗ |
| Larson Jennifer | Chief Financial Officer | A Award deriv | 2026-08-12 | 2026-08-14 | 285,000 | — | $0 | 285,000 | SEC↗ |
| Larson Jennifer | Chief Financial Officer | A Award deriv | 2026-08-12 | 2026-08-14 | 285,000 | — | $0 | 285,000 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2026-08-10 | 2026-08-12 | 18,750 | — | $0 | 51,752 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-08-10 | 2026-08-12 | 10,000 | — | $0 | 110,546 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-08-10 | 2026-08-12 | 12,500 | — | $0 | 26,336 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-08-10 | 2026-08-12 | 18,750 | $27.98 | $524.6K | 181,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2026-08-10 | 2026-08-12 | 18,750 | $3.79 | $71.1K | 200,391 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-08-10 | 2026-08-12 | 10,000 | $3.79 | $37.9K | 372,152 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-08-10 | 2026-08-12 | 10,000 | $27.98 | $279.8K | 362,152 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-08-10 | 2026-08-12 | 12,500 | $27.97 | $349.6K | 129,855 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-08-10 | 2026-08-12 | 12,500 | $3.79 | $47.4K | 142,355 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-08-10 | 2026-08-12 | 12,500 | — | $0 | 26,336 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-08-10 | 2026-08-12 | 12,500 | $27.97 | $349.6K | 129,855 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-08-10 | 2026-08-12 | 12,500 | $3.79 | $47.4K | 142,355 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer, Dir | M Exercise deriv | 2026-08-10 | 2026-08-12 | 10,000 | — | $0 | 110,546 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer, Dir | S Sale | 2026-08-10 | 2026-08-12 | 10,000 | $27.98 | $279.8K | 362,152 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer, Dir | M Exercise | 2026-08-10 | 2026-08-12 | 10,000 | $3.79 | $37.9K | 372,152 | SEC↗ |
| Cohlhepp Ryan | President and COO, Director | M Exercise deriv | 2026-08-10 | 2026-08-12 | 18,750 | — | $0 | 51,752 | SEC↗ |
| Cohlhepp Ryan | President and COO, Director | S Sale | 2026-08-10 | 2026-08-12 | 18,750 | $27.98 | $524.5K | 181,641 | SEC↗ |
| Cohlhepp Ryan | President and COO, Director | M Exercise | 2026-08-10 | 2026-08-12 | 18,750 | $3.79 | $71.1K | 200,391 | SEC↗ |
| Oliger Christy J. | Director | A Award deriv | 2026-07-28 | 2026-07-29 | 38,950 | — | $0 | 38,950 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2026-07-28 | 2026-07-29 | 38,950 | — | $0 | 38,950 | SEC↗ |
| Oliger Christy J. | Director | A Award deriv | 2026-07-28 | 2026-07-29 | 38,950 | — | $0 | 38,950 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2026-07-28 | 2026-07-29 | 38,950 | — | $0 | 38,950 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-07-10 | 2026-07-14 | 10,000 | — | $0 | 120,546 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-07-10 | 2026-07-14 | 28 | $29.68 | $831 | 362,152 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-07-10 | 2026-07-14 | 9,972 | $28.42 | $283.4K | 362,180 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-07-10 | 2026-07-14 | 10,000 | $3.79 | $37.9K | 372,152 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-07-09 | 2026-07-10 | 536 | $29.00 | $15.5K | 181,641 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-07-08 | 2026-07-10 | 908 | — | $0 | 38,836 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-07-08 | 2026-07-10 | 11,592 | — | $0 | 58,992 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2026-07-08 | 2026-07-10 | 18,750 | — | $0 | 70,502 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-07-08 | 2026-07-10 | 4,413 | $29.82 | $131.6K | 130,685 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-07-08 | 2026-07-10 | 22,757 | $28.60 | $650.9K | 135,098 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-07-08 | 2026-07-10 | 12,500 | $3.79 | $47.4K | 157,855 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-07-08 | 2026-07-10 | 830 | $30.31 | $25.2K | 129,855 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-07-08 | 2026-07-10 | 4,306 | $29.80 | $128.3K | 183,252 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-07-08 | 2026-07-10 | 1,075 | $30.35 | $32.6K | 182,177 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-07-08 | 2026-07-10 | 22,833 | $28.76 | $656.7K | 187,558 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2026-07-08 | 2026-07-10 | 18,750 | $3.79 | $71.1K | 210,391 | SEC↗ |
| Simson Jake | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| POWELL MICHAEL | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| Robertson Scott M. | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| Mazumdar-Shaw Kiran | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| Haviland Kate | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| Bowden Christopher | Director | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-05-21 | 2026-05-26 | 9,200 | — | $0 | 70,584 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-05-21 | 2026-05-26 | 9,200 | $20.42 | $187.9K | 145,355 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-05-21 | 2026-05-26 | 9,200 | $3.79 | $34.9K | 154,555 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-05-18 | 2026-05-20 | 15,000 | — | $0 | 146,107 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-05-18 | 2026-05-20 | 2,978 | $20.35 | $60.6K | 362,152 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-05-18 | 2026-05-20 | 15,000 | $3.79 | $56.9K | 377,152 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-05-18 | 2026-05-20 | 12,022 | $19.96 | $240.0K | 365,130 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2026-05-15 | 2026-05-18 | 8,000 | — | $0 | 101,334 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-05-15 | 2026-05-18 | 4,500 | $20.29 | $91.3K | 191,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-05-15 | 2026-05-18 | 8,000 | $20.29 | $162.3K | 196,141 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2026-05-15 | 2026-05-18 | 8,000 | $3.79 | $30.3K | 204,141 | SEC↗ |
| Schelman William | Chief Medical Officer | A Award deriv | 2026-05-08 | 2026-05-12 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2026-04-27 | 2026-04-28 | 5,500 | — | $0 | 41,913 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2026-04-27 | 2026-04-28 | 5,500 | $3.79 | $20.8K | 60,786 | SEC↗ |
| Raben David | Chief Medical Officer | S Sale | 2026-04-27 | 2026-04-28 | 5,500 | $22.88 | $125.8K | 55,286 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-04-21 | 2026-04-22 | 9,200 | — | $0 | 39,744 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-04-21 | 2026-04-22 | 9,200 | $3.79 | $34.9K | 154,555 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-04-21 | 2026-04-22 | 9,200 | $23.00 | $211.6K | 145,355 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-04-20 | 2026-04-20 | 15,000 | — | $0 | 161,107 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-04-20 | 2026-04-20 | 15,000 | $3.79 | $56.9K | 377,152 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-04-20 | 2026-04-20 | 15,000 | $23.61 | $354.1K | 362,152 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-04-16 | 2026-04-20 | 7,454 | — | $0 | 130,546 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-04-16 | 2026-04-20 | 7,080 | — | $0 | 558,432 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-04-16 | 2026-04-20 | 8,226 | — | $0 | 56,684 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-04-16 | 2026-04-20 | 7,080 | $5.45 | $38.6K | 362,152 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-04-16 | 2026-04-20 | 7,454 | $3.79 | $28.3K | 355,072 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-04-16 | 2026-04-20 | 8,226 | $4.44 | $36.5K | 347,618 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2026-04-15 | 2026-04-17 | 8,000 | — | $0 | 109,334 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2026-04-15 | 2026-04-17 | 8,000 | $3.79 | $30.3K | 208,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-04-15 | 2026-04-17 | 8,000 | $23.01 | $184.1K | 200,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-04-15 | 2026-04-17 | 4,500 | $23.01 | $103.5K | 196,141 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2026-03-25 | 2026-03-26 | 5,500 | — | $0 | 47,413 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2026-03-25 | 2026-03-26 | 5,500 | $3.79 | $20.8K | 60,786 | SEC↗ |
| Raben David | Chief Medical Officer | S Sale | 2026-03-25 | 2026-03-26 | 5,500 | $18.95 | $104.2K | 55,286 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-03-23 | 2026-03-24 | 9,200 | — | $0 | 48,944 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-03-23 | 2026-03-24 | 9,200 | $18.52 | $170.4K | 145,355 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-03-23 | 2026-03-24 | 9,200 | $3.79 | $34.9K | 154,555 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-03-20 | 2026-03-20 | 1,596 | — | $0 | 176,107 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-03-20 | 2026-03-20 | 1,596 | $3.79 | $6.0K | 340,988 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-03-20 | 2026-03-20 | 1,596 | $18.95 | $30.2K | 339,392 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-03-19 | 2026-03-20 | 6,905 | — | $0 | 177,703 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-03-19 | 2026-03-20 | 6,905 | $3.79 | $26.2K | 346,297 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-03-19 | 2026-03-20 | 6,905 | $18.78 | $129.7K | 339,392 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-03-18 | 2026-03-20 | 6,499 | — | $0 | 184,608 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-03-18 | 2026-03-20 | 6,499 | $3.79 | $24.6K | 345,891 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-03-18 | 2026-03-20 | 6,499 | $18.84 | $122.4K | 339,392 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2026-03-16 | 2026-03-17 | 8,000 | — | $0 | 117,334 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2026-03-16 | 2026-03-17 | 8,000 | $3.79 | $30.3K | 213,141 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-03-16 | 2026-03-17 | 4,500 | $19.66 | $88.5K | 200,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-03-16 | 2026-03-17 | 8,000 | $19.66 | $157.3K | 205,141 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-03-09 | 2026-03-11 | 36,766 | — | $0 | 191,107 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-03-09 | 2026-03-11 | 36,766 | $3.79 | $139.3K | 376,158 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-03-09 | 2026-03-11 | 36,766 | $19.17 | $704.8K | 339,392 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-03-06 | 2026-03-06 | 3,817 | — | $0 | 227,873 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-03-06 | 2026-03-06 | 3,817 | $3.79 | $14.5K | 343,209 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-03-06 | 2026-03-06 | 3,817 | $18.75 | $71.6K | 339,392 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-03-05 | 2026-03-06 | 1,786 | — | $0 | 231,690 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-03-05 | 2026-03-06 | 1,786 | $3.79 | $6.8K | 341,178 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-03-05 | 2026-03-06 | 1,786 | $18.74 | $33.5K | 339,392 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2026-03-04 | 2026-03-05 | 16,300 | — | $0 | 52,913 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-03-04 | 2026-03-05 | 2,963 | — | $0 | 79,784 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2026-03-04 | 2026-03-06 | 2,631 | — | $0 | 233,476 | SEC↗ |
| Raben David | Chief Medical Officer | S Sale | 2026-03-04 | 2026-03-05 | 16,300 | $18.52 | $301.9K | 55,286 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2026-03-04 | 2026-03-05 | 16,300 | $3.79 | $61.8K | 71,586 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-03-04 | 2026-03-05 | 2,963 | $3.79 | $11.2K | 148,318 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-03-04 | 2026-03-05 | 2,963 | $18.25 | $54.1K | 145,355 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2026-03-04 | 2026-03-06 | 2,631 | $18.73 | $49.3K | 339,392 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2026-03-04 | 2026-03-06 | 2,631 | $3.79 | $10.0K | 342,023 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2026-03-03 | 2026-03-05 | 200 | — | $0 | 69,213 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-03-03 | 2026-03-05 | 7,318 | — | $0 | 58,144 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-03-03 | 2026-03-05 | 6,237 | — | $0 | 82,747 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2026-03-03 | 2026-03-05 | 12,892 | — | $0 | 125,334 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2026-03-03 | 2026-03-05 | 200 | $3.79 | $758 | 55,486 | SEC↗ |
| Raben David | Chief Medical Officer | S Sale | 2026-03-03 | 2026-03-05 | 200 | $18.45 | $3.7K | 55,286 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-03-03 | 2026-03-05 | 7,318 | $3.79 | $27.7K | 152,673 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-03-03 | 2026-03-05 | 6,237 | $3.79 | $23.6K | 158,910 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-03-03 | 2026-03-05 | 13,555 | $18.22 | $247.0K | 145,355 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-03-03 | 2026-03-05 | 4,500 | $18.16 | $81.7K | 205,141 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2026-03-03 | 2026-03-05 | 12,892 | $3.79 | $48.9K | 222,533 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-03-03 | 2026-03-05 | 12,892 | $18.16 | $234.1K | 209,641 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | P Buy deriv | 2026-02-26 | 2026-03-02 | 2,200,000 | $16.00 | $35.20M | 2,200,000 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | P Buy | 2026-02-26 | 2026-03-02 | 300,000 | $16.00 | $4.80M | 4,603,418 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2026-02-25 | 2026-02-27 | 3,108 | — | $0 | 138,226 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-02-25 | 2026-02-27 | 523 | $18.04 | $9.4K | 209,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-02-25 | 2026-02-27 | 3,108 | $18.04 | $56.1K | 210,164 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2026-02-25 | 2026-02-27 | 3,108 | $3.79 | $11.8K | 213,272 | SEC↗ |
| Meisner Lara | Chief Legal Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Raben David | Chief Medical Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | A Award deriv | 2026-02-02 | 2026-02-04 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Cohlhepp Ryan | President and COO | A Award deriv | 2026-02-02 | 2026-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2026-01-22 | 2026-01-26 | 1,882 | — | $0 | 65,462 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2026-01-22 | 2026-01-26 | 1,882 | $18.15 | $34.2K | 145,355 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2026-01-22 | 2026-01-26 | 1,882 | $3.79 | $7.1K | 147,237 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-01-22 | 2026-01-26 | 3,828 | $18.10 | $69.3K | 210,164 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2026-01-15 | 2026-01-20 | 149 | $18.02 | $2.7K | 213,992 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2025-12-26 | 2025-12-29 | 19,789 | — | $0 | 98,987 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2025-12-26 | 2025-12-29 | 25,000 | — | $0 | 39,909 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2025-12-26 | 2025-12-29 | 19,789 | $3.79 | $75.0K | 55,286 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2025-12-26 | 2025-12-29 | 25,000 | $4.44 | $111.0K | 214,141 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2025-12-22 | 2025-12-23 | 9,200 | — | $0 | 88,984 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2025-12-22 | 2025-12-23 | 9,200 | $18.31 | $168.5K | 145,355 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2025-12-22 | 2025-12-23 | 9,200 | $3.79 | $34.9K | 154,555 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2025-12-16 | 2025-12-18 | 29,500 | — | $0 | 565,512 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2025-12-16 | 2025-12-18 | 29,500 | $5.45 | $160.8K | 339,392 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2025-12-15 | 2025-12-16 | 8,000 | — | $0 | 141,334 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2025-12-15 | 2025-12-16 | 8,000 | $3.79 | $30.3K | 201,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-12-15 | 2025-12-16 | 8,000 | $18.68 | $149.4K | 193,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-12-15 | 2025-12-16 | 4,500 | $18.68 | $84.1K | 189,141 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2025-11-25 | 2025-11-25 | 4,594 | — | $0 | 118,776 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2025-11-25 | 2025-11-25 | 906 | — | $0 | 69,413 | SEC↗ |
| Raben David | Chief Medical Officer | S Sale | 2025-11-25 | 2025-11-25 | 4,594 | $18.84 | $86.6K | 35,497 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2025-11-25 | 2025-11-25 | 4,594 | $3.79 | $17.4K | 40,091 | SEC↗ |
| Raben David | Chief Medical Officer | S Sale | 2025-11-25 | 2025-11-25 | 906 | $18.84 | $17.1K | 35,497 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2025-11-25 | 2025-11-25 | 906 | $3.79 | $3.4K | 36,403 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2025-11-24 | 2025-11-25 | 5,500 | — | $0 | 123,370 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2025-11-24 | 2025-11-25 | 41,163 | — | $0 | 236,107 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2025-11-24 | 2025-11-25 | 17,795 | — | $0 | 98,184 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2025-11-24 | 2025-11-25 | 5,500 | $3.79 | $20.8K | 40,997 | SEC↗ |
| Raben David | Chief Medical Officer | S Sale | 2025-11-24 | 2025-11-25 | 5,500 | $18.45 | $101.5K | 35,497 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2025-11-24 | 2025-11-25 | 41,163 | $3.79 | $156.0K | 351,055 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2025-11-24 | 2025-11-25 | 41,163 | $18.86 | $776.3K | 309,892 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2025-11-24 | 2025-11-25 | 17,795 | $18.55 | $330.1K | 145,355 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2025-11-24 | 2025-11-25 | 17,795 | $3.79 | $67.4K | 163,150 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2025-11-21 | 2025-11-25 | 8,000 | — | $0 | 149,334 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2025-11-21 | 2025-11-25 | 605 | — | $0 | 115,979 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-11-21 | 2025-11-25 | 8,000 | $18.05 | $144.4K | 198,141 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-11-21 | 2025-11-25 | 4,500 | $18.05 | $81.2K | 193,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2025-11-21 | 2025-11-25 | 8,000 | $3.79 | $30.3K | 206,141 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2025-11-21 | 2025-11-25 | 605 | $18.15 | $11.0K | 145,355 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2025-11-21 | 2025-11-25 | 605 | $3.79 | $2.3K | 145,960 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2025-10-16 | 2025-10-20 | 24,103 | — | $0 | 277,270 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2025-10-16 | 2025-10-20 | 24,103 | $3.79 | $91.4K | 333,995 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2025-10-16 | 2025-10-20 | 24,103 | $18.83 | $453.9K | 309,892 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2025-10-15 | 2025-10-15 | 13,289 | — | $0 | 301,373 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2025-10-15 | 2025-10-16 | 8,000 | — | $0 | 157,334 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2025-10-15 | 2025-10-15 | 13,289 | $18.84 | $250.4K | 309,892 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2025-10-15 | 2025-10-15 | 13,289 | $3.79 | $50.4K | 323,181 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2025-10-15 | 2025-10-16 | 8,000 | $3.79 | $30.3K | 210,641 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-10-15 | 2025-10-16 | 4,500 | $18.16 | $81.7K | 198,141 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-10-15 | 2025-10-16 | 8,000 | $18.16 | $145.3K | 202,641 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise deriv | 2025-10-13 | 2025-10-15 | 11,445 | — | $0 | 314,662 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | M Exercise | 2025-10-13 | 2025-10-15 | 11,445 | $3.79 | $43.4K | 321,337 | SEC↗ |
| Mazumdar Claire | Chief Executive Officer | S Sale | 2025-10-13 | 2025-10-15 | 11,445 | $18.92 | $216.5K | 309,892 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2025-10-09 | 2025-10-10 | 6,415 | — | $0 | 116,584 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise deriv | 2025-10-09 | 2025-10-10 | 22,000 | — | $0 | 128,870 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2025-10-09 | 2025-10-10 | 6,415 | $18.23 | $116.9K | 145,355 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2025-10-09 | 2025-10-10 | 6,415 | $3.79 | $24.3K | 151,770 | SEC↗ |
| Raben David | Chief Medical Officer | S Sale | 2025-10-09 | 2025-10-10 | 22,000 | $18.45 | $405.9K | 35,497 | SEC↗ |
| Raben David | Chief Medical Officer | M Exercise | 2025-10-09 | 2025-10-10 | 22,000 | $3.79 | $83.4K | 57,497 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2025-10-08 | 2025-10-08 | 5,627 | — | $0 | 122,999 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2025-10-08 | 2025-10-08 | 5,627 | $3.79 | $21.3K | 150,982 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2025-10-08 | 2025-10-08 | 5,627 | $18.21 | $102.5K | 145,355 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2025-10-07 | 2025-10-08 | 8,000 | — | $0 | 165,334 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2025-10-07 | 2025-10-08 | 18,244 | — | $0 | 128,626 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2025-10-07 | 2025-10-08 | 8,000 | $3.79 | $30.3K | 213,541 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-10-07 | 2025-10-08 | 8,000 | $18.06 | $144.5K | 205,541 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-10-07 | 2025-10-08 | 2,900 | $18.06 | $52.4K | 202,641 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2025-10-07 | 2025-10-08 | 18,244 | $3.79 | $69.1K | 163,599 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2025-10-07 | 2025-10-08 | 18,244 | $18.22 | $332.4K | 145,355 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise deriv | 2025-10-06 | 2025-10-08 | 24,000 | — | $0 | 173,334 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise deriv | 2025-10-06 | 2025-10-08 | 6,514 | — | $0 | 146,870 | SEC↗ |
| Cohlhepp Ryan | President and COO | M Exercise | 2025-10-06 | 2025-10-08 | 24,000 | $3.79 | $91.0K | 245,141 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-10-06 | 2025-10-08 | 24,000 | $18.06 | $433.4K | 221,141 | SEC↗ |
| Cohlhepp Ryan | President and COO | S Sale | 2025-10-06 | 2025-10-08 | 15,600 | $18.06 | $281.7K | 205,541 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | M Exercise | 2025-10-06 | 2025-10-08 | 6,514 | $3.79 | $24.7K | 151,869 | SEC↗ |
| Hyep Ivan | Chief Financial Officer | S Sale | 2025-10-06 | 2025-10-08 | 6,514 | $18.17 | $118.4K | 145,355 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2025-09-29 | 2025-10-01 | 33,807 | — | $0 | 101,423 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2025-09-29 | 2025-10-01 | 33,807 | $14.75 | $498.7K | 0 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2025-09-29 | 2025-10-01 | 33,807 | $9.24 | $312.4K | 33,807 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2025-09-15 | 2025-09-17 | 9,744 | — | $0 | 87,699 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2025-09-15 | 2025-09-17 | 6,085 | — | $0 | 54,769 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2025-09-15 | 2025-09-17 | 15,829 | $5.45 | $86.3K | 15,829 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2025-09-15 | 2025-09-17 | 15,829 | $11.49 | $181.9K | 0 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2025-06-16 | 2025-06-18 | 6,085 | — | $0 | 60,854 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2025-06-16 | 2025-06-18 | 9,744 | — | $0 | 97,443 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2025-06-16 | 2025-06-18 | 15,829 | $5.45 | $86.3K | 15,829 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2025-06-16 | 2025-06-18 | 15,829 | $10.43 | $165.1K | 0 | SEC↗ |
| Bowden Christopher | Director | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| Simson Jake | Director | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| Robertson Scott M. | Director | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| LONBERG NILS | Director | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| POWELL MICHAEL | Director | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| Haviland Kate | Director | A Award deriv | 2025-06-09 | 2025-06-10 | 23,746 | — | $0 | 23,746 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2025-03-14 | 2025-03-18 | 30,246 | — | $0 | 67,119 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2025-03-14 | 2025-03-18 | 48,720 | — | $0 | 107,187 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2025-03-14 | 2025-03-18 | 79,146 | $5.45 | $431.3K | 79,145 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2025-03-14 | 2025-03-18 | 48,526 | $12.69 | $615.8K | 30,620 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2025-03-14 | 2025-03-18 | 30,620 | $13.24 | $405.4K | 0 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | C Conversion deriv | 2024-09-17 | 2024-09-17 | 7,973,325 | — | $0 | 0 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | C Conversion deriv | 2024-09-17 | 2024-09-17 | 7,973,325 | — | $0 | 0 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | P Buy | 2024-09-17 | 2024-09-17 | 35,000 | $18.00 | $630.0K | 897,587 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | P Buy | 2024-09-17 | 2024-09-17 | 35,000 | $18.00 | $630.0K | 897,587 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | C Conversion | 2024-09-17 | 2024-09-17 | 862,587 | — | $0 | 862,587 | SEC↗ |
| Deerfield Private Design Fund | 10% Owner | C Conversion | 2024-09-17 | 2024-09-17 | 862,587 | — | $0 | 862,587 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-16 | 40,000,000 | — | $0 | 0 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-16 | 4,000,000 | — | $0 | 0 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-16 | 3,000,000 | — | $0 | 0 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-16 | 9,990,144 | — | $0 | 0 | SEC↗ |
| Biocon Ltd | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-16 | 9,990,144 | — | $0 | 0 | SEC↗ |
| Biocon Ltd | 10% Owner | C Conversion deriv | 2024-09-16 | 2024-09-16 | 40,000,000 | — | $0 | 0 | SEC↗ |
| FMR LLC | Other | C Conversion deriv | 2024-09-16 | 2024-09-18 | 392,085 | — | $0 | 0 | SEC↗ |
| FMR LLC | Other | C Conversion deriv | 2024-09-16 | 2024-09-18 | 10,818 | — | $0 | 0 | SEC↗ |
| FMR LLC | Other | C Conversion deriv | 2024-09-16 | 2024-09-18 | 712,430 | — | $0 | 0 | SEC↗ |
| FIL Ltd | Other | C Conversion deriv | 2024-09-16 | 2024-09-18 | 352,876 | — | $0 | 0 | SEC↗ |
| FIL Ltd | Other | C Conversion deriv | 2024-09-16 | 2024-09-18 | 54,092 | — | $0 | 0 | SEC↗ |
| FIL Ltd | Other | C Conversion deriv | 2024-09-16 | 2024-09-18 | 606,885 | — | $0 | 0 | SEC↗ |
| BONDERMAN DAVID | Other | C Conversion deriv | 2024-09-16 | 2024-09-18 | 18,121,194 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | C Conversion deriv | 2024-09-16 | 2024-09-18 | 10,836,474 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | C Conversion deriv | 2024-09-16 | 2024-09-18 | 5,835,024 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | C Conversion deriv | 2024-09-16 | 2024-09-18 | 12,273,169 | — | $0 | 0 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | C Conversion deriv | 2024-09-16 | 2024-09-18 | 18,409,755 | — | $0 | 0 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-16 | 324,552 | — | $0 | 324,552 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-16 | 1,080,775 | — | $0 | 1,080,775 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-16 | 4,327,365 | — | $0 | 4,443,122 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | C Conversion | 2024-09-16 | 2024-09-16 | 432,736 | — | $0 | 432,736 | SEC↗ |
| Biocon Ltd | 10% Owner | C Conversion | 2024-09-16 | 2024-09-16 | 4,327,365 | — | $0 | 4,443,122 | SEC↗ |
| Biocon Ltd | 10% Owner | C Conversion | 2024-09-16 | 2024-09-16 | 1,080,775 | — | $0 | 1,080,775 | SEC↗ |
| FMR LLC | Other | C Conversion | 2024-09-16 | 2024-09-18 | 392,085 | — | $0 | 1,115,333 | SEC↗ |
| FMR LLC | Other | C Conversion | 2024-09-16 | 2024-09-18 | 10,818 | — | $0 | 10,818 | SEC↗ |
| FMR LLC | Other | C Conversion | 2024-09-16 | 2024-09-18 | 712,430 | — | $0 | 723,248 | SEC↗ |
| FIL Ltd | Other | C Conversion | 2024-09-16 | 2024-09-18 | 54,092 | — | $0 | 54,092 | SEC↗ |
| FIL Ltd | Other | C Conversion | 2024-09-16 | 2024-09-18 | 606,885 | — | $0 | 660,977 | SEC↗ |
| FIL Ltd | Other | C Conversion | 2024-09-16 | 2024-09-18 | 352,876 | — | $0 | 1,013,853 | SEC↗ |
| BONDERMAN DAVID | Other | C Conversion | 2024-09-16 | 2024-09-18 | 1,960,425 | — | $0 | 1,960,425 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | C Conversion | 2024-09-16 | 2024-09-18 | 2,622,898 | — | $0 | 2,622,898 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | P Buy | 2024-09-16 | 2024-09-18 | 152,480 | $18.00 | $2.74M | 2,652,575 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | P Buy | 2024-09-16 | 2024-09-18 | 1,680,520 | $18.00 | $30.25M | 4,303,418 | SEC↗ |
| RA Capital Nexus Fund III, L.P | Director | C Conversion | 2024-09-16 | 2024-09-18 | 2,500,095 | — | $0 | 2,500,095 | SEC↗ |
| Mazumdar-Shaw Kiran | Director, 10% Owner | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |
| Robertson Scott M. | Director | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |
| Haviland Kate | Director | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |
| Simson Jake | Director | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |
| LONBERG NILS | Director | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | A Award deriv | 2024-09-12 | 2024-09-16 | 23,746 | — | $0 | 23,746 | SEC↗ |